動物用成長促進剤およびパフォーマンス向上剤の市場：種類別（抗生物質および非抗生物質（ホルモン、酸味料、飼料酵素、プロバイオティクス＆プレバイオティクス、フィトジェニック））、動物タイプ別（家禽、豚、家畜、水産養殖） - 2026年までの世界予測

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026

動物の成長促進剤とパフォーマンス向上剤の世界市場は、2021年の162億米ドルから2026年には214億米ドルに達すると予測され、年平均成長率は5.7%となっています。成長促進剤や性能向上剤を含む動物用医薬品は、... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年10月29日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	241	172	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

動物の成長促進剤とパフォーマンス向上剤の世界市場は、2021年の162億米ドルから2026年には214億米ドルに達すると予測され、年平均成長率は5.7%となっています。成長促進剤や性能向上剤を含む動物用医薬品は、動物の成長に使用される薬剤や化学物質の一種です。これらの増強剤は、食物をより効果的に消化し、動物がより早く成長することを可能にし、その結果、生産性の向上に役立ちます。動物用成長促進剤および性能向上剤市場の成長は、主に動物消費量および畜産物消費量の増加、天然由来の成長促進剤に対する世界的な需要の高まり、動物伝染病の増加および気候変動が要因となっています。しかし、さまざまな国での抗生物質の使用禁止や、動物の成長促進のための抗生物質やホルモンの使用を制限する厳しい規制が、予測期間中の動物用成長促進剤・パフォーマンスエンハンサー市場の成長を抑制すると予想されます。

"動物用成長促進剤・パフォーマンス向上剤市場では、非抗生物質系成長促進剤・パフォーマンス向上剤のセグメントが最大のシェアを占めると予想されます"

2020年の動物用成長促進剤およびパフォーマンス向上剤市場では、非抗生物質の成長促進剤およびパフォーマンス向上剤セグメントが最大のシェアを占めています。このセグメントのシェアが大きいのは、これらの製品の経済的メリット、さまざまな生産動物への応用が可能な幅広い物質、環境の持続性、抗生物質やホルモン剤に対する規制の増加などが理由として挙げられます。

"動物用成長促進剤・パフォーマンスエンハンサー市場では、家禽分野が最大のシェアを占めると予想されています。"

動物の種類別に見ると、家禽セグメントが世界の動物成長促進剤およびパフォーマンス向上剤市場で最大のシェアを占めています。これは、家禽類の肉や卵の需要が増加していること、新しい食生活のアプローチが増えていること、抗生物質の段階的な廃止により代替品の開発が進んでいることなどが要因となっています。

"予測期間中、アジア太平洋地域が動物成長促進剤およびパフォーマンス向上剤市場を支配する"

アジア太平洋地域が最大のシェアを占め、2020年には北米がシェアを獲得して続く。アジア太平洋地域の大きなシェアは、この地域の強力な動物製品産業、巨大な人口による国内の食肉需要の増加、比較的緩和された規制シナリオ、動物生産者を奨励する政府の取り組みなどに起因しています。

本レポートで言及している動物用成長促進剤・パフォーマンスエンハンサー市場の主要参加企業の内訳は以下の通りです。

- 企業タイプ別。Tier1-40%、Tier2-30%、Tier3-30%。

- デザイン別 Cレベル：27%、ディレクターレベル：18%、その他：55

- 地域別北米-50%、欧州-20%、アジア太平洋-15%、RoW-15

動物用成長促進剤・パフォーマンスエンハンサー市場の有力企業には、Cargill, Incorporated（米国）、Royal DSM N.V.（オランダ）、Elanco Animal Health Incorporated（米国）、Boehringer Ingelheim Group（ドイツ）、Merck & Co, Inc（米国）、Alltech Corporation（米国）、Archer-Daniels-Midland Company（ADM）（米国）、Vetoquinol S.A. （フランス）、Bupo Animal Health Pty Ltd（南アフリカ）、Novus International, Inc. (米国)、Associated British Foods plc(英国)、Erber AG(オーストリア)、Phibro Animal Health Corporation(米国)、Kemin Industries, Inc. (米国)、Zoetis Inc. (米国)、Nutreco N.V.(オランダ)、Novozymes A/S(デンマーク)、BASF SE(ドイツ)、Evonik Industries AG(ドイツ)、Bluestar Adisseo Company(中国)、Land O'Lakes, Inc. (米国）、Chr.Hansen（デンマーク）、Biomin Holding GmbH（オーストリア）、Guangdong VTR Bio-Tech Co. (中国)、Lallemand Inc. (カナダ)があります。

調査範囲

当レポートでは、様々な動物の成長促進剤やパフォーマンス向上剤の市場とその採用パターンについて分析しています。世界の動物成長促進剤とパフォーマンスエンハンサー市場の市場規模と将来の成長性を推定し、タイプ、動物の種類、地域などの異なるセグメントを目的としています。また、この市場の主要企業の会社概要、製品・サービス内容、最近の動向など、詳細な競合分析も行っています。

レポートを購入する理由

本レポートは、既存の企業だけでなく、新規参入企業や小規模な企業にとっても、市場の動向を把握するのに役立ち、その結果、より大きなシェアを獲得することができます。本レポートを購入した企業は、市場での存在感を高めるために、以下の5つの戦略のうち、1つまたは複数の組み合わせを利用することができます。

本レポートでは、以下の項目について分析しています。

- 市場への浸透。世界の動物成長促進剤・パフォーマンスエンハンサー市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報

- 製品開発/イノベーション。動物成長促進剤とパフォーマンスエンハンサーの世界市場における今後の動向、研究開発活動、製品やサービスの発表についての詳細な洞察

- 市場開発タイプ別、動物タイプ別、地域別の収益性の高い新興地域に関する包括的な情報

- 市場の多様化。世界の動物成長促進剤およびパフォーマンスエンハンサー市場における新製品、成長地域、および最近の開発状況に関する網羅的な情報。

- 競合他社の評価。世界の動物成長促進剤・パフォーマンスエンハンサー市場における主要企業の市場シェア、成長戦略、収益分析、製品・サービスについての詳細な評価。

ページTOPに戻る

Table of Contents

Summary

The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period.

“The non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.

“Poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”
Based on animal type, the poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.
“Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period”
Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.

A breakdown of the primary participants for the animal growth promoters and performance enhancers market referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%
• By Designation: C-level–27%, Director Level–18%, and Others–55%
• By Region: North America–50%, Europe–20%, Asia Pacific–15%, RoW- 15%

The prominent players in the animal growth promoters and performance enhancers market include Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd (South Africa), Novus International, Inc. (US), Associated British Foods plc (UK), Erber AG (Austria), Phibro Animal Health Corporation (US), Kemin Industries, Inc. (US), Zoetis Inc. (US), Nutreco N.V. (Netherlands), Novozymes A/S (Denmark), BASF SE (Germany), Evonik Industries AG (Germany), Bluestar Adisseo Company (China), Land O’Lakes, Inc. (US), Chr. Hansen (Denmark), Biomin Holding GmbH (Austria), Guangdong VTR Bio-Tech Co., Ltd. (China), and Lallemand Inc. (Canada).

Research Coverage:
The report analyzes the market for various animal growth promoters and performance enhancers and their adoption pattern. It aims at estimating the market size and future growth potential of the global animal growth promoters and performance enhancers market and different segments such as type, animal type and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global animal growth promoters and performance enhancers market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global animal growth promoters and performance enhancers market
• Market Development: Comprehensive information on the lucrative emerging regions by type, animal type, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global animal growth promoters and performance enhancers market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global animal growth promoters and performance enhancers market.

ページTOPに戻る

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET SEGMENTATION 28
FIGURE 2 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY REGION 29
1.4 YEARS CONSIDERED FOR THE STUDY 29
1.5 CURRENCY 30
TABLE 1 STANDARD CURRENCY CONVERSION RATES 30
1.6 LIMITATIONS 30
1.7 STAKEHOLDERS 31
1.8 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 3 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
FIGURE 4 PRIMARY SOURCES 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Key industry insights 38
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 38
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 39
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ROYAL DSM N.V. 40
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020) 41
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR 42
FIGURE 11 CAGR PROJECTIONS 42
FIGURE 12 TOP-DOWN APPROACH 43

2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 RISK ASSESSMENT 46
3 EXECUTIVE SUMMARY 47
FIGURE 14 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 47
FIGURE 15 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 48
FIGURE 16 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION) 48
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET 49
4 PREMIUM INSIGHTS 50
4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW 50
FIGURE 18 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH 50
4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2020) 51
FIGURE 19 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 51
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 52
FIGURE 20 EUROPEAN COUNTRIES TO WITNESS HIGH CAGR DURING
THE FORECAST PERIOD 52
4.4 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
REGIONAL MIX 53
FIGURE 21 ASIA PACIFIC IS THE LARGEST MARKET FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Increase in demand and consumption of livestock-based products 55
TABLE 2 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS 55
FIGURE 23 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 56
FIGURE 24 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 56
5.2.1.2 Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters 57
5.2.1.3 Rise in the global demand for naturally produced growth promoters 58
5.2.1.4 Rise in awareness about growth promoters 58
FIGURE 25 US: ANTIBIOTICS SALES (2018) 58
5.2.1.5 Rise in animal epidemics and climate change 59
5.2.2 RESTRAINTS 60
5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals 60
5.2.2.2 Ban on antibiotics in different nations 60
TABLE 3 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Focus on increasing environmental sustainability 61
5.2.4 CHALLENGES 62
5.2.4.1 Increasing global feed tonnage and high feed costs
leading to the adoption of conventional feeding systems 62
5.2.4.2 Growing threat of disease transmission to and from agricultural animals 63
6 INDUSTRY INSIGHTS 64
6.1 INDUSTRY TRENDS 64
6.1.1 INVESTMENT TOWARDS NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 64
TABLE 4 INVESTMENT TOWARDS ANIMAL GROWTH PROMOTERS 64
6.1.2 GROWING CONSOLIDATION IN THE ANIMAL HEALTH INDUSTRY 64
TABLE 5 MAJOR ACQUISITIONS IN THE ANIMAL HEALTH INDUSTRY (2017–2019) 65
6.2 PRICING ANALYSIS 65
TABLE 6 AVERAGE SELLING PRICE OF ANIMAL GROWTH PROMOTERS 65
TABLE 7 SIMULATION OF THE ECONOMIC IMPACT OF REMOVING ANTIBIOTIC GROWTH PROMOTERS (AGP) 66
6.3 VALUE CHAIN ANALYSIS 66
FIGURE 26 VALUE CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 67
6.4 ECOSYSTEM MAPPING 67
FIGURE 27 ECOSYSTEM ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 68
6.5 SUPPLY CHAIN ANALYSIS 68
FIGURE 28 SUPPLY CHAIN ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 69
6.6 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 8 PORTERS FIVE FORCES ANALYSIS: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2020) 70
6.6.1 INTENSITY OF COMPETITIVE RIVALRY 70
6.6.2 BARGAINING POWER OF SUPPLIERS 70
6.6.3 BARGAINING POWER OF BUYERS 71
6.6.4 THREAT OF NEW ENTRANTS 71
6.6.5 THREAT OF SUBSTITUTES 71
6.7 REGULATORY ANALYSIS 72
FIGURE 29 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 74
FIGURE 30 APPROVAL PROCESS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS IN EUROPE 75
6.8 PATENT ANALYSIS 76
6.8.1 PATENT PUBLICATION TRENDS FOR ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 76
FIGURE 31 GLOBAL PATENT PUBLICATION TRENDS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, 2015–2020 76
6.9 TRADE ANALYSIS 77
TABLE 9 IMPORT SHIPMENT RELATED TO ANIMAL GROWTH PROMOTERS 77
6.10 IMPACT OF THE COVID-19 PANDEMIC ON THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 77
7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE
ENHANCERS MARKET, BY TYPE 79
7.1 INTRODUCTION 80
TABLE 10 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 80
7.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 80
TABLE 11 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 80
TABLE 12 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
7.2.1 PREBIOTICS & PROBIOTICS 81
7.2.1.1 Prebiotics & probiotics hold the largest share of the market 81
TABLE 13 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
7.2.2 ACIDIFIERS 83
7.2.2.1 Regulations on antibiotics and wide applications in different production animals to drive the use of acidifiers 83
TABLE 14 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.2.3 PHYTOGENICS 84
7.2.3.1 Natural performance enhancement and antioxidative & disease defense properties to support the use of phytogenics 84
TABLE 15 PHYTOGENICS GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 85
7.2.4 FEED ENZYMES 85
7.2.4.1 Feed enzymes segment to benefit from the bans on antibiotics and hormones 85

TABLE 16 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.2.5 HORMONES 86
7.2.5.1 Human health implications and restricted usage due to regulations to hamper the growth of the hormones segment 86
TABLE 17 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
7.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 88
TABLE 18 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89
7.3 ANTIBIOTIC GROWTH PROMOTERS 89
7.3.1 ANTIBIOTIC GROWTH PROMOTERS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS 89
TABLE 19 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US (2019) 90
TABLE 20 ANTIBIOTICS BANS AND REGULATIONS, BY COUNTRY 91
TABLE 21 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 92
8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE 93
8.1 INTRODUCTION 94
TABLE 22 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 94
8.2 POULTRY 94
8.2.1 THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2020 94
TABLE 23 IMPORTANT STATISTICS RELATED TO POULTRY MEAT (2020) 95
TABLE 24 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.3 LIVESTOCK 96
8.3.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 96
TABLE 25 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR LIVESTOCK, BY COUNTRY, 2019–2026 (USD MILLION) 97
8.4 SWINE 98
8.4.1 RISING DEMAND FOR PORK MEAT AND THE INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAK TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 98
TABLE 26 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION) 99
8.5 AQUATIC ANIMALS 99
8.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS 99
TABLE 27 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 100

8.6 OTHER ANIMALS 100
TABLE 28 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 101
9 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION 102
9.1 INTRODUCTION 103
FIGURE 32 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD 103
TABLE 29 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2019–2026 (USD MILLION) 104
9.2 ASIA PACIFIC 105
FIGURE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT 105
TABLE 30 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 31 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 32 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 33 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 107
9.2.1 CHINA 108
9.2.1.1 China to dominate the APAC animal growth promoters and performance enhancers market 108
TABLE 34 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 35 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 109
TABLE 36 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 109
9.2.2 INDIA 110
9.2.2.1 Large livestock population and increased production and export capacities to drive market growth 110
TABLE 37 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 38 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 111
TABLE 39 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 111
9.2.3 JAPAN 112
9.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers to drive the demand for growth promoters in Japan 112
TABLE 40 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 41 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 42 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 113
9.2.4 AUSTRALIA 114
9.2.4.1 Large cattle population and heavy meat exports to support the market in Australia 114
TABLE 43 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 44 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 45 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 115
9.2.5 REST OF ASIA PACIFIC 116
9.2.5.1 Lack of a defined regulatory scenario to result in the wide use of antibiotic growth promoters in the RoAPAC 116
TABLE 46 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY 116
TABLE 47 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 48 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 49 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 117
9.3 NORTH AMERICA 118
TABLE 50 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
TABLE 51 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 52 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 53 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 119
9.3.1 US 120
9.3.1.1 Increasing meat consumption to drive the market in the US 120
FIGURE 34 US: GROWTH IN BEEF CONSUMPTION, 2014–2019 (BILLION POUNDS) 120
TABLE 54 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 55 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 56 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 122
9.3.2 CANADA 122
9.3.2.1 Production and export of meat and aquaculture in Canada to drive the market growth 122
TABLE 57 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019 123
TABLE 58 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 59 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 60 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 124
9.4 EUROPE 125
FIGURE 35 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT 125
TABLE 61 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 62 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 63 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 64 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 127
9.4.1 UK 127
9.4.1.1 Preventive measures to avoid the risk of zoonotic diseases to drive the market in the UK 127
TABLE 65 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 66 UK: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 67 UK: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 128
9.4.2 GERMANY 129
9.4.2.1 Increasing veterinary visits and growing healthcare expenditure to boost the growth of the market in Germany 129
FIGURE 36 SALES SURVEILLANCE OF ANTIMICROBIALS FOR VETERINARY USE IN GERMANY (2011 TO 2018) 129
TABLE 68 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 69 GERMANY: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 70 GERMANY: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 130
9.4.3 SWITZERLAND 131
9.4.3.1 Increasing milk demand to drive the market in Switzerland 131
TABLE 71 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 72 SWITZERLAND: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 73 SWITZERLAND: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 132
9.4.4 RUSSIA 132
9.4.4.1 Russia to hold the largest share of the European market due to its large poultry production 132
TABLE 74 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 75 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 76 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 133
9.4.5 REST OF EUROPE 134
9.4.5.1 Technological advancements and the strong trade industry to support the RoE market 134
TABLE 77 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 78 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 79 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 135
9.5 LATIN AMERICA 136
TABLE 80 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 81 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 82 LATIN AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 83 LATIN AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 137
9.5.1 BRAZIL 137
9.5.1.1 Brazil to dominate the Latin American market for animal growth promoters and performance enhancers 137
TABLE 84 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 85 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 86 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 138
9.5.2 REST OF LATIN AMERICA 138
9.5.2.1 Strong demand for animal products and support initiatives to help the market in the RoLA 138
TABLE 87 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 88 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 89 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 140
9.6 MIDDLE EAST 140
9.6.1 INCREASING DEMAND FOR CHICKEN AND SEAFOOD TO CONTRIBUTE TO MARKET GROWTH IN THE MIDDLE EAST 140
TABLE 90 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 91 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 92 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 141

9.7 AFRICA 141
9.7.1 RELIANCE ON CONVENTIONAL LIVESTOCK PRODUCTION PRACTICES TO HAMPER THE MARKET GROWTH IN AFRICA 141
TABLE 93 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 94 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 95 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 143
10 COMPETITIVE LANDSCAPE 144
10.1 INTRODUCTION 144
FIGURE 37 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021) 144
10.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 145
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 145
10.3 MARKET SHARE ANALYSIS 145
FIGURE 39 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SHARE, BY KEY PLAYER, 2020 146
10.4 COMPETITIVE SCENARIO 147
10.4.1 PRODUCT LAUNCHES 147
TABLE 96 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: PRODUCT LAUNCHES (JANUARY 2018 TO AUGUST 2021) 147
10.4.2 DEALS 148
TABLE 97 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DEALS (JANUARY 2018 TO AUGUST 2021) 148
10.4.3 OTHER DEVELOPMENTS 149
TABLE 98 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO AUGUST 2021) 149
10.5 COMPETITIVE BENCHMARKING 150
10.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS 150
10.5.2 PRODUCT TYPE FOOTPRINT OF COMPANIES 151
10.5.3 ANIMAL TYPE FOOTPRINT OF COMPANIES 152
10.5.4 REGIONAL FOOTPRINT OF COMPANIES 153
10.6 GEOGRAPHIC FOOTPRINT OF COMPANIES 154
10.6.1 GEOGRAPHIC REVENUE MIX: KEY PLAYERS 154
10.7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET:
R&D EXPENDITURE 155
10.7.1 R&D EXPENDITURE OF KEY PLAYERS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET (2019 VS. 2020) 155
10.8 COMPANY EVALUATION MATRIX 155
10.8.1 STARS 156
10.8.2 EMERGING LEADERS 156
10.8.3 PERVASIVE PLAYERS 156
10.8.4 EMERGING COMPANIES 156
FIGURE 40 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: GLOBAL COMPANY EVALUATION MATRIX 157
10.9 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 158
10.9.1 PROGRESSIVE COMPANIES 158
10.9.2 STARTING BLOCKS 158
10.9.3 RESPONSIVE COMPANIES 158
10.9.4 DYNAMIC COMPANIES 158
FIGURE 41 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS 159
11 COMPANY PROFILES 160
11.1 KEY PLAYERS 160
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CARGILL, INCORPORATED 160
TABLE 99 CARGILL, INCORPORATED: BUSINESS OVERVIEW 160
11.1.2 ROYAL DSM N.V. 165
TABLE 100 ROYAL DSM N.V.: BUSINESS OVERVIEW 165
FIGURE 42 COMPANY SNAPSHOT: ROYAL DSM N.V. (2020) 166
11.1.3 ELANCO ANIMAL HEALTH INCORPORATED 170
TABLE 101 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW 170
FIGURE 43 COMPANY SNAPSHOT: ELANCO ANIMAL HEALTH INCORPORATED (2020) 171
11.1.4 BOEHRINGER INGELHEIM GROUP 174
TABLE 102 BOEHRINGER INGELHEIM GROUP: BUSINESS OVERVIEW 174
FIGURE 44 COMPANY SNAPSHOT: BOEHRINGER INGELHEIM GROUP (2020) 175
11.1.5 MERCK & CO., INC. 178
TABLE 103 MERCK & CO., INC.: BUSINESS OVERVIEW 178
FIGURE 45 COMPANY SNAPSHOT: MERCK & CO., INC. (2020) 179
11.1.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM) 182
TABLE 104 ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OVERVIEW 182
FIGURE 46 COMPANY SNAPSHOT: ARCHER-DANIELS-MIDLAND COMPANY (2020) 183
11.1.7 BLUESTAR ADISSEO COMPANY 188
TABLE 105 BLUESTAR ADISSEO COMPANY: BUSINESS OVERVIEW 188
FIGURE 47 COMPANY SNAPSHOT: BLUESTAR ADISSEO COMPANY (2020) 189
11.1.8 ALLTECH CORPORATION 191
TABLE 106 ALLTECH CORPORATION: BUSINESS OVERVIEW 191
11.1.9 EVONIK INDUSTRIES AG 194
TABLE 107 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW 194
FIGURE 48 COMPANY SNAPSHOT: EVONIK INDUSTRIES AG (2020) 195
11.1.10 VETOQUINOL S.A. 197
TABLE 108 VETOQUINOL S.A.: BUSINESS OVERVIEW 197

11.2 OTHER PLAYERS 200
11.2.1 BUPO ANIMAL HEALTH PTY LTD. 200
TABLE 109 BUPO ANIMAL HEALTH PTY LTD: BUSINESS OVERVIEW 200
11.2.2 NOVUS INTERNATIONAL, INC. 202
TABLE 110 NOVUS INTERNATIONAL, INC.: BUSINESS OVERVIEW 202
11.2.3 ASSOCIATED BRITISH FOODS PLC 205
TABLE 111 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 205
FIGURE 49 COMPANY SNAPSHOT: ASSOCIATED BRITISH FOODS PLC (2020) 206
11.2.4 ERBER AG 208
TABLE 112 ERBER AG: BUSINESS OVERVIEW 208
11.2.5 PHIBRO ANIMAL HEALTH CORPORATION 211
TABLE 113 PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW 211
FIGURE 50 COMPANY SNAPSHOT: PHIBRO ANIMAL HEALTH CORPORATION (2020) 212
11.2.6 KEMIN INDUSTRIES, INC. 215
TABLE 114 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW 215
11.2.7 ZOETIS INC. 219
TABLE 115 ZOETIS INC.: BUSINESS OVERVIEW 219
FIGURE 51 COMPANY SNAPSHOT: ZOETIS INC. (2020) 220
11.2.8 NUTRECO N.V. (A WHOLLY-OWNED SUBSIDIARY OF SHV GROUP) 222
TABLE 116 NUTRECO N.V.: BUSINESS OVERVIEW 222
FIGURE 52 COMPANY SNAPSHOT: SHV GROUP (2020) 223
11.2.9 NOVOZYMES A/S 226
TABLE 117 NOVOZYMES A/S.: BUSINESS OVERVIEW 226
FIGURE 53 COMPANY SNAPSHOT: NOVOZYMES A/S (2020) 227
11.2.10 BASF SE 229
TABLE 118 BASF SE: BUSINESS OVERVIEW 229
FIGURE 54 COMPANY SNAPSHOT: BASF SE (2020) 230
11.2.11 LAND O’LAKES, INC. 232
11.2.12 CHR. HANSEN A/S 233
11.2.13 BIOMIN HOLDING GMBH 234
11.2.14 GUANGDONG VTR BIO-TECH CO., LTD. 235
11.2.15 LALLEMAND INC. 236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 237
12.1 DISCUSSION GUIDE 237
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 243
12.3 AVAILABLE CUSTOMIZATIONS 245
12.4 RELATED REPORTS 245
12.5 AUTHOR DETAILS 246

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（feed）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（feed）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?